本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2014/1/231 分钟阅读
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →